Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has been assigned a consensus recommendation of “Buy” from the seven ...

At close: March 28 at 4:00:00 PM EDT ...

Investing.com — Nektar Therapeutics（音译：耐科特治疗公司）的股票面临显著下跌，触及52周低点0.65美元，仅在过去一周就下跌了18.8%。根据 InvestingPro ...

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Nektar Therapeutics (NKTR – Research Report), with a ...

Investing.com — 生物制药公司Nektar Therapeutics (NASDAQ: NKTR )今日宣布与销售代理商Piper Sandler & Co.和BTIG, LLC签订了一项价值高达7500万美元的股权分配协议，此举旨在加强其财务状况。

EDT Nektar (NKTR) files $300M mixed securities shelfLight Up your Portfolio with Spark:Easily identify stocks' risks and opportunities.

The fireside chat will be accessible via the webcast link above as well as on the Investor Events section of the Nektar website: https://ir.nektar.com/events-and ...